Advertisement

Acta Parasitologica

, Volume 59, Issue 2, pp 206–212 | Cite as

Clinico-pathological studies of Plasmodium falciparum and Plasmodium vivax — malaria in India and Saudi Arabia

Original Paper
  • 112 Downloads

Abstract

Malaria is one of the most devastating diseases of tropical countries with clinical manifestations such as anaemia, splenomegaly, thrombocytopenia, hepatomegaly and acute renal failures. In this study, cases of thrombocytopenia and haemoglobinemia were more prominent in subjects infected with Plasmodium falciparum (Welch, 1897) than those with Plasmodium vivax (Grassi et Feletti, 1890). However, anaemia, jaundice, convulsions and acute renal failure were significantly high (3–4 times) in subjects infected with P. falciparum than those infected with P. vivax. The incidence of splenomegaly and neurological sequelae were 2 and 6 times higher in P. falciparum infections compared to the infections of P. vivax. Both in P. vivax and P. falciparum malaria, the cases of splenomegaly, jaundice and neurological sequelae were almost double in children (<10 years) compared to older patients. The liver enzymes were generally in normal range in cases of low and mild infections. However, the AST, ALT, ALP activities and serum bilirubin, creatinine, and the urea content were increased in P. falciparum and P. vivax malaria patients having high parasitaemia, confirming liver dysfunction and renal failures in few cases of severe malaria both in India and Saudi Arabia.

Keywords

Pathology liver enzymes splenomegaly malaria India Saudi Arabia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahsan T., Ali H., Bkaht S.F., Ahmad N., Farooq M.U., Shaheer A., Mahmood T. 2008. Jaundice and P. falciparum malaria: Changing trends in clinical presentation-A need for awareness. Journal Pakistan Medical Association, 58, 616–621.Google Scholar
  2. Anikar A.R., Singh D.K., Singh R., Das A.P., Valeecha N. 2010. Vivax malaria presenting with cerebral malaria and convulsions. Acta Parasitologica, 55, 96–98.CrossRefGoogle Scholar
  3. Banzal S., Ayoola F.A., El Sammani F.E., Rahim S.I., Subramanium P., Gadour M.O.E., Jain A.K. 1999. The clinical pattern and complications of severe malaria in the Jazan region of Saudi Arabia. Annals Saudi Medicine, 19, 378–380.Google Scholar
  4. Bashawri L.A., Mandil A.A., Bahnassy A.A., Ahmed M.A., Al-Shamsi M.A., Bukhari H.A. 2001. Epidemiological profile of malaria in a university hospital in eastern region of Saudi Arabia. Saudi Med. J. 22,133–138.Google Scholar
  5. Brewster D.R., Kwiatkowski D., White N. J. 1990. Neurological sequelae of cerebral malaria in children. Lancet, 27,336(8722), 1039–1043.CrossRefGoogle Scholar
  6. Burtis C.A., Ashood E.R. (Eds.). 1999. Text Book of clinical chemistry, Philadelphia, Saunders Company, pp. 616–721.Google Scholar
  7. Chawla L.S., Sidhu G., Sabharwal B.D., Bhatia K.L., Sood A. 1989. Jaundice in P. falciparum. Journal of the Association of Physicians of India, 37, 390–392.PubMedGoogle Scholar
  8. Douglas N.M., Anstey N.M., Buffet P.A., Poespoprodjo J.R., Yeo T., White N.J., Price R.N. 2012. The anaemia of Plasmodium vivax malaria. Malaria Journal, 11, 135. DOI: 10.1186/1475-2875-11-135.PubMedCentralPubMedCrossRefGoogle Scholar
  9. Echeverri M., Tobon A., Alvarez G., Carmona J., Blair S. 2003. Clinical and laboratory findings of Plasmodium vivax malaria in Columbia 2001. Revista do Instituto de Medicina Tropical de São Paulo, 45, 29–34.PubMedCrossRefGoogle Scholar
  10. Engwerda C.R., Beattie L., Amante F.H. 2005. The importance of the spleen in malaria. Trends in Parasitology, 21, 75–80.PubMedCrossRefGoogle Scholar
  11. Harris V.K., Richard V.S., Mathi E., Sitaram U., Kumar K.V., Cherian A.M., Amelia S.M., Anand G. 2001. A study on clinical profile of P. falciparum malaria in a tertiary care hospital in south India. Indian Journal of Malariology, 38, 19–24.PubMedGoogle Scholar
  12. Idro R., Ndiritu M., Ogutu B., Mithwani S., Maitland K., Berkley J., Crawley J., Fegan G., Bauni E., Peshu N., Marsh K., Neville B., Newton C. 2007. Burden, features, and outcome of neurological involvement in acute P. falciparum malaria in Kenyan children. Journal of the American Medical Association, 297, 2232–2240.PubMedCentralPubMedCrossRefGoogle Scholar
  13. Jadhav U.M., Patkar V.S., Kadam N.N. 2004. Thrombocytopaenia in malaria-correlated with type and severity of malaria. Journal of the Association of Physicians of India, 52, 615–618.PubMedGoogle Scholar
  14. Joseph V., Verma M., Vidhyasagar S., Mathew A. 2011. Comparision of clinical profile and complications of mixed malarial infections of P. falciparum and P. vivax versus P. falciparum Monoinfection. Sultan Qaboos University Medical Journal, 11, 377–382.PubMedCentralPubMedGoogle Scholar
  15. Kalpana A. (Ed.). 1965. Standard Methods of Clinical Chemistry. New York Academic Press. pp. 245–256.Google Scholar
  16. Kochar D.K., Das A., Kochar A., Midha S., Acharya J., Tanwar G.S., Gupta A., Pakalapati D., Garg S., Saxena V., Subudhi A.K., Boopathi P.A., Sirohi P., Kochar S.K. 2010. Thrombocytopenia in P. falciparum, P. vivax and mixed infection malaria: A study from Bikaner (North western India). Platelets, 21, 623–627.PubMedCrossRefGoogle Scholar
  17. Kochar D.K., Kaswan K., Kochar S.K., Sirohi P., Pal M., Kochar A. 2006. A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis. Journal of Vector Borne Diseases, 43, 123–129.PubMedGoogle Scholar
  18. Lança E.F.C., MagalhĂes B.M.L., Vitor-Silva S., Siqueira A.M., Benzecry S.G., Alexandre M.A.A., O’Brien C., Bassat Q., Lacerda M.V.G. 2012. Risk factors and characterization of Plasmodium vivax-associated admissions to Pediatric Intensive Care Units in the Brazilian Amazon. PLoS ONE, 7(4), e35406.PubMedCentralPubMedCrossRefGoogle Scholar
  19. Limaye S.L., Londhey V.A., Nabar S.T. 2012. The study of complications of vivax malaria in comparision with P. falciparum malaria in Mumbai. Journal of the Association of Physicians of India, 60, 15–18.PubMedGoogle Scholar
  20. Maheshwari A., Singh A.K., Sinha D.K., Tripathy K., Prakash J. 2004. Spectrum of renal disease in malaria. Journal of the Indian Medical Association,102, 143–146.PubMedGoogle Scholar
  21. Malik G.M., Seidi O., El-Taher A.M., Mohammad A.S. 1998. Clinical aspect of malaria in the Asir region Saudi Arabia. Annals of Saudi Medicine, 18, 15–17.PubMedGoogle Scholar
  22. Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., Newton C., Winstanley P., Warn P., Peshu N. 1995. Indicators of life-threatening malaria in African children. New England Medical Journal, 332, 1399–1404.CrossRefGoogle Scholar
  23. Mazumder R., Mishra R.K., Mazumdar H., Mukherjee P. 2002. Jaundice and P. falciparum malaria: Some prospective observations. Journal of the Indian Medical Association, 100, 312–314.PubMedGoogle Scholar
  24. Mehta K.S., Halankar A.R., Makwana P.D., Torane P.P., Satija P.S., Shah V.B. 2001. Severe acute renal failure in malaria. Journal of Postgraduate Medicine, 47, 24–26.PubMedGoogle Scholar
  25. Naqvi R., Ahmad E., Akhtar F., Naqvi A., Rizvi A. 2003. Outcome in severe acute renal failure associated with malaria. Nephrology Dialysis Transplantation, 18, 1820–1823.CrossRefGoogle Scholar
  26. Ngoungou E.B., Poudiougou B., Dulac O., Dicko A., Boncoeur M.P., Traoré A.M., Coulibaly D., Keita M.M., Preux P.M., Doumbo O.K., Druet-Cabanac M. 2007. Persistent neurological sequelae due to cerebral malaria in a cohort of children from Mali. Review Neurology, (Paris),163, 583–588.CrossRefGoogle Scholar
  27. Onyesom, Onyemakonor N. 2011. Level of parasitaemia and changes in some liver enzymes among malarial infected patients in Edo-Delta region of Nigeria. Current Research Journal of Biological Sciences, 3, 78–81.Google Scholar
  28. Parakash J., Singh A.K., Kumar N.S., Saksena R.K. 2003. Acute renal failure in Plasmodium vivax malaria. Journal of the Association of Physicians of India, 51, 265–267.Google Scholar
  29. Picot S., Bienvenu A.L. 2009. [Plasmodium vivax infection: not so benign]. Medical Science, (Paris), 25, 622–626. DOI: 10.1051/medsci/2009256-7622.CrossRefGoogle Scholar
  30. Quintero J. P., Siqueira A.M., Tobón A., Blair S., Moreno A., Arévalo-Herrera M., Lacerda M.V., Valencia S.H. 2011. Malariarelated anaemia: a Latin American perspective. Memórias do Instituto Oswaldo Cruz, 106 Suppl.,1, 91–104.Google Scholar
  31. Rodrigues-Morales A.J., Sanchez E., Vergas M., Piccolo C., Colina R., Arria M. 2006. Anaemia and thrombocytopaenia in children with Plasmodium vivax malaria. Journal of Tropical Pediatrics, 52, 49–51.CrossRefGoogle Scholar
  32. Sharma A., Khanduri U. 2009. How benign is benign tertian malaria?. Journal of Vector Borne Diseases, 46, 141–144.PubMedGoogle Scholar
  33. Singh H., Parakh A., Basu S., Rath B. 2011. Plasmodium vivax malaria: is it actually benign? Journal of Infection and Public Health, 4, 91–95.PubMedCrossRefGoogle Scholar
  34. Sonkar S.K., Uniyal R., Sonkar G.K. 2011. Three unusual presentations of Plasmodium vivax malaria. Tropical Doctor, 41, 240–241.PubMedCrossRefGoogle Scholar
  35. Srivastava S., Ahmad S., Shirazi N., Kumar Verma S., Puri P. 2011. Retrospective analysis of vivax malaria patients presenting to tertiary referral centre Uttarakhand. Acta Tropica, 117, 82–85.PubMedCrossRefGoogle Scholar
  36. Tangpukdee N., Thanachartwet V., Krudsood S., Luplertlop N., Pornpininworakij K., Chalermrut K., Phokham S., Kano S., Looareesuwan S., Wilairatana P. 2006. Minor liver profile dysfunctions in Plasmodium vivax, P. malariae and P. ovale patients and normalization after treatment. Korean Journal of Parasitology, 4, 295–302.CrossRefGoogle Scholar
  37. Thanachachartwet V., Desacorn V., Sahassananda D., Win K.Y.K.K., Supaporn T. 2013. Acute renal failure in patients with severe falciparum malaria: Using the WHO 2006 and RIFLE Criteria. International Journal of Nephrology. Article ID841518, 6 pages. http://dx.doi.org/ 10.1155/2013/841518.Google Scholar
  38. Thomas L. (Ed.). 1998. Clinical Laboratory diagnostics. Frankfurt, TH-Books Verlagsgesellschaft, 366–374.Google Scholar
  39. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M. Lampah D.A., Price N.R. 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Medicine, 5, e128. DOI: 10.1371/journal.pmed.0050128.PubMedCentralPubMedCrossRefGoogle Scholar
  40. Tripathy R., Parida S., Das L., Mishra D.P., Tripathy D., Das M.C., Chen H., Maguire J.H., Panigrahi P. 2007. Clinical manifestations and predictors of severe malaria in Indian children. Pediatrics, 120, e454–460.PubMedCrossRefGoogle Scholar
  41. Uzuegbu U.E., Emeka C.B. 2011. Changes in liver function markers among malaria infected patients in Ikeja Lagos State, Nigeria. Current Research Journal of Biological Sciences, 3, 172–174.Google Scholar
  42. Vannaphan S., Walters N., Saengnedsawang T., Tangpukdee N., Kham-In P., Molleudee K., Wilairatana P., Looareesuwan S., 2010. Factors Associated with acute renal failure in severe P. falciparum malaria patients. Southeast Asian Journal of Tropical Medicine and Public Health, 41, 1042–1047.PubMedGoogle Scholar
  43. Wickramasinghe S.M., Abdallah S.H. 2000: Blood and bone marrow changes in Malaria. Baillieres Best Practice & Research Clinical Haematology, 13, 277–299.CrossRefGoogle Scholar
  44. Wilkinson J.H., Baron D.N., Moss D.W., Walker P.G. 1972. Standardization of clinical enzyme assays: A reference method for aspartate and alanine transaminases. Journal of Clinical Pathology, 25, 940.PubMedCentralPubMedCrossRefGoogle Scholar
  45. World Health Organization (WHO). World Malaria Report 2011. www.who.int/malaria/publications/atoz.Google Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Wien 2014

Authors and Affiliations

  1. 1.Faculty of Applied Medical SciencesKing Abdulaziz UniversityJeddahKingdom of Saudi Arabia
  2. 2.Department of Zoology, Faculty of Life SciencesAligarh Muslim UniversityAligarhIndia

Personalised recommendations